Cytomed Therapeutics Ltd (GDTC)

Jul 27, 2026

CytoMed Therapeutics Ltd (GDTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026

Jul 27, 2026

CytoMed Therapeutics Ltd (GDTC) Institutional Confidence - TradingKey

Jul 27, 2026

Jul 27, 2026

GDTC|CytoMed Therapeutics Ltd|Price:0.871|Chg%:-0.119 - TradingKey

Jul 27, 2026

Jul 27, 2026

CytoMed Therapeutics Ltd (GDTC) Cash Flow - TradingKey

Jul 27, 2026

Jul 27, 2026

CytoMed Therapeutics Ltd (GDTC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 27, 2026

Jul 27, 2026

CytoMed Therapeutics Ltd (GDTC) Balance Sheet - TradingKey

Jul 27, 2026

Jul 26, 2026

CytoMed Therapeutics Ltd (GDTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 26, 2026

Jul 26, 2026

CytoMed Therapeutics Ltd (GDTC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 26, 2026

Jul 26, 2026

CytoMed Therapeutics Ltd (GDTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 26, 2026

Jul 26, 2026

CytoMed Therapeutics Ltd (GDTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 26, 2026

Jul 26, 2026

GDTC|CytoMed Therapeutics Ltd|Price:0.990|Chg%:+0.140 - TradingKey

Jul 26, 2026

Jul 25, 2026

CytoMed Therapeutics Ltd (GDTC) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 25, 2026

Jul 25, 2026

CytoMed Therapeutics Ltd (GDTC) Income Statement - TradingKey

Jul 25, 2026

Jul 24, 2026

Form 13D/A CytoMed Therapeutics Ltd For: 24 July By Investing.com - Investing.com South Africa

Jul 24, 2026

Jul 24, 2026

CytoMed Therapeutics (GDTC) director adds 200,000 shares in July buys - Stock Titan

Jul 24, 2026

Jul 24, 2026

Form 4 CytoMed Therapeutics Ltd For: 24 July By Investing.com - Investing.com South Africa

Jul 24, 2026

Jul 24, 2026

CytoMed Therapeutics (GDTC) insider discloses two ordinary share dispositions - Stock Titan

Jul 24, 2026

Jul 24, 2026

CytoMed Therapeutics' US$1.7m Market Cap Fall Books Insider Losses - simplywall.st

Jul 24, 2026

Jul 24, 2026

Cytomed director, 10% owner Choo Chee Kong acquires $300,000 in common shares - Bitget

Jul 24, 2026

Jul 15, 2026

CytoMed Therapeutics Ltd – An Emerging Star in Singapore’s Cancer Biotechnology Sector - FinancialContent

Jul 15, 2026

Jul 14, 2026

CytoMed Therapeutics(GDTC) Stock Options Chain | Quotes & News - Moomoo

Jul 14, 2026

Jul 13, 2026

CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting) - Moomoo

Jul 13, 2026

Jul 10, 2026

CytoMed Therapeutics (GDTC) Stock Forecast & Analyst Ratings - Moomoo

Jul 10, 2026

Jul 09, 2026

CytoMed Therapeutics Ltd (NASDAQ: GDTC) – A Rising Star in Singapore’s Cancer Biotechnology Sector - FinancialContent

Jul 09, 2026

Jul 05, 2026

GDTCCytoMed Therapeutics Ltd Options - Finviz

Jul 05, 2026

Jun 29, 2026

CytoMed, a Singapore Biotech, RevolutionizesCancer Treatment Using Donor Immune Cells - openPR.com

Jun 29, 2026

Jun 24, 2026

CytoMed Chairman Boosts Personal Stake and Funds R&D Expansion at LongevityBank - The Globe and Mail

Jun 24, 2026

Jun 23, 2026

Form 6K CytoMed Therapeutics Ltd For: 23 June - Investing.com UK

Jun 23, 2026

Jun 23, 2026

Form 6K CytoMed Therapeutics Ltd For: 23 June By Investing.com - Investing.com Australia

Jun 23, 2026

Jun 23, 2026

CytoMed Therapeutics (NASDAQ: GDTC) chair ups exposure and funds LongevityBank R&D - Stock Titan

Jun 23, 2026

Jun 17, 2026

CytoMed Therapeutics Ltd (GDTC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 15, 2026

CytoMed Therapeutics (NASDAQ: GDTC) director buys 112,000 shares in open market - Stock Titan

Jun 15, 2026

Jun 03, 2026

CytoMed Therapeutics (NASDAQ: GDTC) shareholders approve all AGM proposals - Stock Titan

Jun 03, 2026

Jun 01, 2026

CytoMed Therapeutics (GDTC) Dips 2.48% as Key Support at $1.08 Comes into FocusDouble Top - newsline.com

Jun 01, 2026

May 26, 2026

CytoMed Therapeutics (NASDAQ: GDTC) director discloses holding 4,000 Ordinary Shares - Stock Titan

May 26, 2026

May 21, 2026

CytoMed Therapeutics LtdA Rising Star in Singapore's Cancer Biotechnology Sector - openPR.com

May 21, 2026

May 18, 2026

CytoMed Therapeutics Limited is accelerating its international expansion - openPR.com

May 18, 2026

May 15, 2026

CytoMed Therapeutics (NASDAQ: GDTC) director reports 2,469 ordinary shares on Form 3 - Stock Titan

May 15, 2026

May 15, 2026

CytoMed Therapeutics (NASDAQ: GDTC) director files initial Form 3 ownership - Stock Titan

May 15, 2026

May 15, 2026

CytoMed Therapeutics (NASDAQ: GDTC) director Choo Chee Kong details direct and indirect share ownership - Stock Titan

May 15, 2026

May 15, 2026

CytoMed Therapeutics (NASDAQ: GDTC) CFO reports holding 25,781 ordinary shares - Stock Titan

May 15, 2026

May 15, 2026

CytoMed Therapeutics (GDTC) chair adds 112,000 shares in private purchase - Stock Titan

May 15, 2026

May 13, 2026

[144] CytoMed Therapeutics Ltd SEC Filing - Stock Titan

May 13, 2026

May 11, 2026

GDTC Price Today: CytoMed Therapeutics Limited Stock Price, Quote & Chart | MEXC - MEXC

May 11, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 11, 2026

CytoMed Renames Subsidiary to Drive Asian and International Expansion - TipRanks

May 11, 2026